Skip to content

Countries and donors should aim for new $90-$90-$90 target on HIV, hepatitis, TB drug prices, study shows

Dzintars Gotham presenting at IAS 2017. Image credit: Enzo Poultreniez / http://aides.org

90-90-90 progress in southern Africa: HIV testing gap needs to be closed in young people and men

Staff conducting the population-based HIV impact assessments (PHIA). Image credit: http://phia.icap.columbia.edu

New guidance says start HIV treatment within 7 days of diagnosis – but is everyone ready?

Presentation by Brendan Maughan-Brown at IAS 2017. www.ias2017.org

Hepatitis C treatment is effective and feasible in Africa

Karine Lacombe of Saint-Antoine Hospital, Paris, at IAS 2017. Photo by Liz Highleyman, hivandhepatitis.com

Less frequent clinic visits for HIV care: fine tuning needed

MSF Community Adherence Club KwaZulu-Natal. Photo by Greg Lomas / Scholars and Gentlemen / Médecins sans Frontières

Swaziland: new infections halved in five years as HIV treatment scales up

Velephi Okello at IAS 2017. Photo by Liz Highleyman, hivandhepatitis.com

World on track to reach the 90-90-90 targets for HIV treatment by 2020

Michel Sidibé at IAS 2017. Photo by Marcus Rose/IAS

Gay men using HIV self-tests promptly seek confirmatory testing and linkage to care, New York data suggests

High uptake of home-based HIV testing in Zambia, but repeat visits needed to get close to universal coverage